BKS Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,000	Closed	-$614K	–	219
2018 Q3	$614K	Buy	+5,000	New	+$614K	0.23%	113